Biomerieux Pathology Reagents
The Regional Health Contracting Office - Pacific, in support of MEDCOM, Korea, intends to make a sole source award to CheonKwang Science Co. for a blanket purchase agreement for Biomerieux Pathology Reagents validated for use with existing Government-owned equipment for MEDCOM, Korea. The statutory authority permitting this award without providing full and open competition is FAR 13.501(a)(1)(ii) which authorizes the government to award contracts when there is only one responsible source and no other suppliers or services will satisfy agency requirements.
The NAICS code is 339112. This announcement fulfills the synopsis requirements under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be considered solely for the purpose of determining whether a competitive
procurement is in the best interest of the Government. All questions and responses concerning this notice shall be emailed to wendi.t.young-asao.civ@mail.mil.
Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to
determine the organization's qualifications to supply the required products. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. No proprietary,
classified, confidential, or sensitive information should be included in your response.
Wendi T. Young-Asao, Phone 8084385116, Email wendi.t.young-asao.civ@mail.mil
